Back

The metabolic enzyme EXT1 is sufficient to induce the epithelial-mesenchymal transition program in cancers

Solaimuthu, B.; Khatib, A.; Hayashi, A.; Tanna, M.; Lichtenstein, M.; Karmi, A.; Shaul, Y. D.

2023-01-05 cancer biology
10.1101/2023.01.05.522866 bioRxiv
Show abstract

Carcinomas often exhibit aggressive characteristics, such as enhanced migration abilities, through the execution of the epithelial-mesenchymal transition (EMT) program. Heparan sulfate (HS) is a polysaccharide expressed on the surface of aggressive cancer cells, which acts as a co-receptor to stimulate EMT-associated signaling pathways. However, despite HS role in cancer aggressiveness, the mechanisms governing its EMT-dependent biosynthesis remains poorly understood. Here, we characterized the HS chain elongation enzyme, exostosin glycosyltransferase 1 (EXT1), as an essential component of the EMT program. We identified an EMT-dependent expression of EXT1 and its selective upregulation in aggressive tumor subtypes and cell lines. Overexpression of EXT1 in epithelial cells is sufficient to induce HS biosynthesis, cell migration, and invasion, form tumors in mice, and activate the STAT3 pathway. Moreover, its knockout in aggressive cells significantly inhibited their EMT-associated characteristics. These findings demonstrate a cellular mechanism by which metabolic processes regulate signaling pathways to govern cell state.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

1
Nature Communications
○ 5641 papers in training set
Top 16%
11.6%
Similar papers in this journal
2
Oncogene
○ 85 papers in training set
Top 0.1%
10.4%
Similar papers in this journal
3
Cell Death & Disease
147 papers in training set
Top 0.2%
7.7%
4
Cell Reports
○ 1498 papers in training set
Top 3%
7.7%
Similar papers in this journal
5
eLife
● 5828 papers in training set
Top 20%
6.1%
Similar papers in this journal
6
Cell Death & Differentiation
○ 48 papers in training set
Top 0.1%
5.4%
7
Journal of Experimental & Clinical Cancer Research
○ 25 papers in training set
Top 0.1%
4.0%
50% of probability mass above
8
Proceedings of the National Academy of Sciences
● 2444 papers in training set
Top 15%
3.4%
9
Communications Biology
○ 993 papers in training set
Top 6%
3.2%
10
Science Advances
● 1243 papers in training set
Top 11%
3.2%
11
iScience
○ 1154 papers in training set
Top 8%
3.1%
12
Cancer Letters
○ 35 papers in training set
Top 0.3%
2.6%
13
Cancers
○ 213 papers in training set
Top 2%
2.6%
14
Cancer Research
● 130 papers in training set
Top 2%
2.3%
15
Scientific Reports
○ 3612 papers in training set
Top 50%
1.9%
16
Advanced Science
○ 286 papers in training set
Top 5%
1.7%
17
npj Breast Cancer
○ 23 papers in training set
Top 0.3%
1.6%
18
Molecular Cancer Research
● 49 papers in training set
Top 0.9%
1.3%
19
Redox Biology
○ 70 papers in training set
Top 1%
1.1%
20
Breast Cancer Research
○ 36 papers in training set
Top 0.5%
1.1%
21
Theranostics
● 37 papers in training set
Top 0.8%
1.1%
22
International Journal of Cancer
○ 49 papers in training set
Top 1.0%
1.0%
23
Cancer Research Communications
● 51 papers in training set
Top 2%
0.8%
24
Cell Death Discovery
○ 58 papers in training set
Top 2%
0.6%

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.